The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Open accessAbstract
BACKGROUND: Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with intermittent bolus dosing standard therapy, despite a strong theoretical rationale for continuous administration. The aim of this trial was to determine the clinical and pharmacokinetic differences between continuous and intermittent dosing in patients with severe sepsis. METHODS: This was a prospective, double-blind, randomized controlled trial of continuous infusion versus intermittent bolus dosing of piperacillin-tazobactam, meropenem, and ticarcillin-clavulanate conducted in 5 intensive care units across Australia and Hong Kong. The primary pharmacokinetic outcome on treatment analysis was plasma antibiotic concentration above the minimum inhibitory concentration (MIC) on days 3 and 4. The assessed clinical outcomes were clinical response 7-14 days after study drug cessation, ICU-free days at day 28 and hospital survival. RESULTS: Sixty patients were enrolled with 30 patients each allocated to the intervention and control groups. Plasma antibiotic concentrations exceeded the MIC in 82% of patients (18 of 22) in the continuous arm versus 29% (6 of 21) in the intermittent arm (P = .001). Clinical cure was higher in the continuous group (70% vs 43%; P = .037), but ICU-free days (19.5 vs 17 days; P = .14) did not significantly differ between groups. Survival to hospital discharge was 90% in the continuous group versus 80% in the intermittent group (P = .47). CONCLUSIONS: Continuous administration of beta-lactam antibiotics achieved higher plasma antibiotic concentrations than intermittent administration with improvement in clinical cure. This study provides a strong rationale for further multicenter trials with sufficient power to identify differences in patient-centered endpoints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Assessment of blinding in clinical trials
Bang, H., Ni, L., & Davis, C. E. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2003.10.016 · Cited by 682
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464
Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units
Finfer, S., Bellomo, R., Lipman, J., French, C., Dobb, G., & Myburgh, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2157-0 · Cited by 442
Self-citationRoberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp139 · Cited by 347
Self-citationAntibiotic resistance—What’s dosing got to do with it?
Roberts, J. A., Kruger, P., Paterson, D. L., & Lipman, J. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318180fe62 · Cited by 339
Self-citationA systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
Roberts, J. A., Webb, S., Paterson, D., Ho, K. M., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0054d · Cited by 225
Self-citationAnalysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection
McWhinney, B. C., Wallis, S. C., Hillister, T., Roberts, J. A., Lipman, J., & Ungerer, J. P. J. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.05.027 · Cited by 209
Self-citationViaene, E., Chanteux, H., Servais, H., Mingeot-Leclercq, M.-P., & Tulkens, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2327-2332.2002 · Cited by 190
Martin, C. M., Priestap, F., Fisher, H., Fowler, R. A., Heyland, D. K., Keenan, S. P., Longo, C. J., Morrison, T., Bentley, D., & Antman, N. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819285f0 · Cited by 189
Kasiakou, S. K., Sermaides, G. J., Michalopoulos, A., Soteriades, E. S., & Falagas, M. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70218-8 · Cited by 189
Sakka, S. G., Glauner, A. K., Bulitta, J. B., Kinzig-Schippers, M., Pfister, W., Drusano, G. L., & Sörgel, F. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01318-06 · Cited by 159
Nicolau, D. P., McNabb, J., Lacy, M. K., Quintiliani, R., & Nightingale, C. H. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00329-6 · Cited by 158
Continuous infusion of β-lactam antibiotics in severe infections: a review of its role
Roberts, J. A., Paratz, J., Paratz, E., Krueger, W. A., & Lipman, J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.02.002 · Cited by 150
Self-citationRoberts, J. A., Boots, R. J., Rickard, C. M., Thomas, P., Quinn, J., Roberts, D. M., Richards, B., & Lipman, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl478 · Cited by 138
Self-citationTowards a proposal for assessment of blinding success in clinical trials: up-to-date review
Kolahi, J., Bang, H., & Park, J. (2009) · Community Dentistry and Oral Epidemiology · doi:10.1111/j.1600-0528.2009.00494.x · Cited by 137
Rafati, M. R., Rouini, M. R., Mojtahedzadeh, M., Najafi, A., Tavakoli, H., Gholami, K., & Fazeli, M. R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.020 · Cited by 120
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen
Georges, B., Conil, J., Cougot, P., Decun, J. F., Archambaud, M., Seguin, T., Chabanon, G., Virenque, C., Houin, G., & Saivin, S. (2005) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43360 · Cited by 104
Continuous infusion of beta-lactams
Mouton, J. W., & Vinks, A. A. T. M. M. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3282e2a98f · Cited by 103
Yost, R. J., Cappelletty, D. M., & RECEIPT Study Group (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.8.767 · Cited by 90
Antimicrobial Utilisation in 37 Australian and New Zealand Intensive Care Units
Dulhunty, J. M., Paterson, D. L., Webb, S. A. R., & Lipman, J. (2011) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1103900212 · Cited by 39
Self-citationMcAuley, D. F., O’Kane, C. M., & Griffiths, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f1fcae · Cited by 18
Cited by
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
Self-citationSepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., Goutelle, S., Lefeuvre, S., Mongardon, N., Roger, C., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2378-9 · Cited by 543
Sartelli, M., Chichom-Mefire, A., Labricciosa, F. M., Hardcastle, T., Abu-Zidan, F. M., Adesunkanmi, A. K., Ansaloni, L., Bala, M., Balogh, Z. J., Beltrán, M. A., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0141-6 · Cited by 494
Blot, S. I., Pea, F., & Lipman, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.006 · Cited by 444
Self-citation
Metadata
- Authors
- Dulhunty, J. M., Roberts, J. A., Davis, J. S., Webb, S. A. R., Bellomo, R., Gomersall, C., Shirwadkar, C., Eastwood, G. M., Myburgh, J., Paterson, D. L., & Lipman, J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-16
- Volume
- 56
- Issue
- 2
- Pages
- 236-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2153997139
- Cited by
- 394
- References
- 28
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.